Preglife, the Nordic region’s most downloaded app for pregnant mothers and new parents, is looking to expand globally after raising its first investment. The company’s undisclosed funding round was was led by eEquity, a leading Nordic investor in digital growth companies.
Stockholm-based Preglife launched its app in 2010 and has since been downloaded more than 2.6 million times, boasting over 500,000 current active users.
The app serves as an information source for parents throughout the pregnancy and the actual delivery, allowing expecting mothers to track their pregnancy and providing them with tips, exercises and medical information.
Tobias Meschke, CEO and founder, said:
“Preglife has been completely self-financed. This has resulted in our journey taking a little longer, but has also led to us having a working business model and full control of costs. It feels really exciting to find a professional investor who values our way of working.
“With eEquity as one of our owners, we hope to achieve our goals faster. eEquity has previous experience from building companies with a clear online strategy and global ambitions – which we value. In the coming years we will work hard together in order to become the leading pregnancy and baby application globally.”
Preglife’s app is now available in eight markets and the startup hopes to use the investment to expand to a number of new countries.
“We were immensely impressed by how satisfied Preglife’s users are and how relevant their offering is for the target audience,” added eEquity partner Johan Symmons. “Preglife has, with limited resources, succeeded to build the leading and most complete pregnancy application in the Nordic market, and has also become one of the leading players in both Germany and Poland in a short period of time. Furthermore, we are impressed by the strong and closely-knit partnerships Preglife has with leading commercial players within several industries.
“We are looking forward to supporting the company during its journey to become one of the leading and most relevant pregnancy and baby application globally.”